Thesis
Identification of new therapeutic targets and drug repositioning in myelodysplastic syndromes using transcriptional profiling and connectivity mapping
- Abstract:
-
The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal haematopoietic stem cell (HSC) malignancies that are characterised by ineffective haematopoiesis leading to peripheral blood cytopenias at one or more lineages. There are few effective treatments for this disorder, and the identification of new therapeutic agents in MDS is urgently needed. Drug repurposing is a potential alternative to novel drug discovery by redirecting existing drugs for treating another disease, whi...
Expand abstract
Actions
Authors
Contributors
+ Pellagatti, A
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Role:
Supervisor
ORCID:
0000-0002-6122-0221
+ Boultwood, J
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Role:
Supervisor
ORCID:
0000-0002-4330-2928
+ Pezzella, F
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Role:
Examiner
+ Verma, A
Institution:
Albert Einstein College of Medicine
Role:
Examiner
Funding
+ China Scholarship Council
More from this funder
Funder identifier:
http://dx.doi.org/10.13039/501100004543
Funding agency for:
Sun, T
Bibliographic Details
- Type of award:
- DPhil
- Level of award:
- Doctoral
- Awarding institution:
- University of Oxford
Item Description
- Language:
-
English
- Keywords:
- Subjects:
- Deposit date:
-
2021-07-19
Terms of use
- Copyright holder:
- Sun, T
- Copyright date:
- 2021
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record